CLINICAL_TRIALS ClinicalTrials.gov record update

A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children With Central Precocious Puberty

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00667446
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:34.441270+00:00
Published At: 2013-12-10T00:00:00+00:00
Record Updated At: 2014-01-09
Results Posted At: 2013-12-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Precocious", "Leuprolide Acetate", "Luteinizing Hormone (LH)", "Gonadotrophin-releasing Hormone Agonist (GnRHa)", "Tanner Staging", "Depot Formulation", "Suppression of LH", "Central Precocious Puberty (CPP)", "Gonadotrophin-releasing Hormone (GnRH)", "Lupron", "GnRH Analog", "Pediatrics Central Precocious Puberty"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-01-09"
protocolSection.identificationModule.nctId: "NCT00667446"
protocolSection.identificationModule.officialTitle: "A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children With Central Precocious Puberty"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2013-12-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.